Published in PLoS Med on October 16, 2007
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med (2007) 8.46
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ (2007) 5.38
Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bull World Health Organ (2008) 3.85
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration. PLoS Med (2012) 3.62
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement. PLoS Med (2015) 2.72
Body mass index categories in observational studies of weight and risk of death. Am J Epidemiol (2014) 2.62
Why ethics is indispensable for good-quality operational research. Public Health Action (2012) 2.57
Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens (2014) 2.54
Reporting and methods in clinical prediction research: a systematic review. PLoS Med (2012) 2.26
Use of relative and absolute effect measures in reporting health inequalities: structured review. BMJ (2012) 2.23
Observational studies: cohort and case-control studies. Plast Reconstr Surg (2010) 2.16
Exploration and confirmation of factors associated with uncomplicated pregnancy in nulliparous women: prospective cohort study. BMJ (2013) 2.10
Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am J Epidemiol (2012) 2.07
Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses. PLoS One (2013) 2.05
Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One (2014) 1.92
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. Lancet Oncol (2014) 1.88
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. BMC Med (2012) 1.85
Why match? Investigating matched case-control study designs with causal effect estimation. Int J Biostat (2009) 1.83
Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity. Neurology (2013) 1.82
High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series. Br J Cancer (2009) 1.78
Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother (2013) 1.69
Observational studies: getting clear about transparency. PLoS Med (2014) 1.64
Prevalence of chronic hepatitis B infection in Iran: a review article. J Res Med Sci (2009) 1.51
Systematic review on the health effects of exposure to radiofrequency electromagnetic fields from mobile phone base stations. Bull World Health Organ (2010) 1.51
Does cultural competency training of health professionals improve patient outcomes? A systematic review and proposed algorithm for future research. J Gen Intern Med (2010) 1.50
Maternal oral bacterial levels predict early childhood caries development. J Dent Res (2013) 1.49
San Francisco Syncope Rule to predict short-term serious outcomes: a systematic review. CMAJ (2011) 1.48
Syndemics of psychosocial problems and HIV risk: A systematic review of empirical tests of the disease interaction concept. Soc Sci Med (2015) 1.48
Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS One (2012) 1.43
STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement. PLoS Med (2011) 1.42
Association between routine laboratory tests and long-term mortality among acutely admitted older medical patients: a cohort study. BMC Geriatr (2017) 1.38
Barriers to GPs' use of evidence-based medicine: a systematic review. Br J Gen Pract (2012) 1.38
Does integrated management of childhood illness (IMCI) training improve the skills of health workers? A systematic review and meta-analysis. PLoS One (2013) 1.37
Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLoS Med (2013) 1.31
Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: "STROBE-RDS" statement. J Clin Epidemiol (2015) 1.25
The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag (2014) 1.23
Quality of Cohort Studies Reporting Post the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement. Epidemiol Health (2011) 1.22
Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study. Aliment Pharmacol Ther (2009) 1.19
Medication adherence and health care utilization in pediatric chronic illness: a systematic review. Pediatrics (2013) 1.18
Evaluating mastery of biostatistics for medical researchers: need for a new assessment tool. Clin Transl Sci (2011) 1.15
Gestational diabetes mellitus in Africa: a systematic review. PLoS One (2014) 1.15
Psychosocial adjustment and mental health in former child soldiers--systematic review of the literature and recommendations for future research. J Child Psychol Psychiatry (2012) 1.14
Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique. BMC Infect Dis (2011) 1.12
Epidemiology of glaucoma in sub-saharan Africa: prevalence, incidence and risk factors. Middle East Afr J Ophthalmol (2013) 1.10
Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. PLoS Med (2011) 1.09
Livelihood security and adherence to antiretroviral therapy in low and middle income settings: a systematic review. PLoS One (2011) 1.09
No differences in short-term morbidity and mortality after robot-assisted laparoscopic versus laparoscopic resection for colonic cancer: a case-control study of 263 patients. Surg Endosc (2013) 1.08
Physical activity and cardiovascular risk factors among rural and urban groups and rural-to-urban migrants in Peru: a cross-sectional study. Rev Panam Salud Publica (2010) 1.07
Collaborative pharmaceutical care in an Irish hospital: uncontrolled before-after study. BMJ Qual Saf (2014) 1.06
Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Epidemiol (2011) 1.04
Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults. Cancer (2011) 1.04
Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis (2011) 1.04
Joint and independent effects of alcohol drinking and tobacco smoking on oral cancer: a large case-control study. PLoS One (2013) 1.03
Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria. J Acquir Immune Defic Syndr (2014) 1.03
Establishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up results. Harm Reduct J (2013) 1.02
A review of the reporting and handling of missing data in cohort studies with repeated assessment of exposure measures. BMC Med Res Methodol (2012) 1.02
Prevalence of osteoporosis in Iran: A meta-analysis. J Res Med Sci (2013) 1.02
STRengthening analytical thinking for observational studies: the STRATOS initiative. Stat Med (2014) 1.01
The prevalence of primary angle closure glaucoma in adult Asians: a systematic review and meta-analysis. PLoS One (2014) 1.01
Epidemiology of chronic pain in denmark and sweden. Pain Res Treat (2012) 1.01
Associations between statins and COPD: a systematic review. BMC Pulm Med (2009) 0.99
Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol (2013) 0.97
What influences national and foreign physicians' geographic distribution? An analysis of medical doctors' residence location in Portugal. Hum Resour Health (2012) 0.97
Strengthening the Reporting of Observational Studies in Epidemiology-Nutritional Epidemiology (STROBE-nut): An Extension of the STROBE Statement. PLoS Med (2016) 0.96
Better reporting, better research: guidelines and guidance in PLoS Medicine. PLoS Med (2008) 0.96
Long-term morbidity and mortality in patients without early complications after stroke or transient ischemic attack. CMAJ (2017) 0.95
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Epidemiol (2011) 0.94
Proceedings of the second international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control (2015) 0.94
Blood-borne biomarkers of mortality risk: systematic review of cohort studies. PLoS One (2015) 0.94
What is the evidence for pharmaceutical patient assistance programs? A systematic review. J Health Care Poor Underserved (2011) 0.93
Bladder cancer among hairdressers: a meta-analysis. Occup Environ Med (2010) 0.93
Receipt of recommended surveillance among colorectal cancer survivors: a systematic review. J Cancer Surviv (2013) 0.92
Time-dependent impact of diabetes on mortality in patients with stroke: survival up to 5 years in a health insurance population cohort in Germany. Diabetes Care (2012) 0.92
Failure of hospital employees to comply with smoke-free policy is associated with nicotine dependence and motives for smoking: a descriptive cross-sectional study at a teaching hospital in the United Kingdom. BMC Public Health (2009) 0.92
A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord (2013) 0.92
Postoperative delirium in the intensive care unit predicts worse outcomes in liver transplant recipients. Can J Gastroenterol (2013) 0.92
Impact of selective evidence presentation on judgments of health inequality trends: an experimental study. PLoS One (2013) 0.92
Psychological associations of poststroke fatigue: a systematic review and meta-analysis. Stroke (2014) 0.92
Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study. BMC Pediatr (2013) 0.92
Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia. BMC Psychiatry (2011) 0.91
Comments on Varela-Mato, V.; Cancela, J.M.; Ayan, C.; Martín, V.; Molina, A. Lifestyle and health among Spanish university students: differences by gender and academic discipline. Int. J. Environ. Res. Public Health 2012, 9, 2728-2741. Int J Environ Res Public Health (2013) 0.91
Risk of myocardial infarction and stroke in bipolar disorder: a systematic review and exploratory meta-analysis. Acta Psychiatr Scand (2014) 0.90
A review of published analyses of case-cohort studies and recommendations for future reporting. PLoS One (2014) 0.90
Measuring oral contraceptive knowledge: a review of research findings and limitations. Patient Educ Couns (2010) 0.90
Better reporting of scientific studies: why it matters. PLoS Med (2013) 0.90
Prevalence of high blood pressure in 122,053 adolescents: a systematic review and meta-regression. Medicine (Baltimore) (2014) 0.89
Risk factors for adverse prognosis and death in American visceral leishmaniasis: a meta-analysis. PLoS Negl Trop Dis (2014) 0.89
Search strings for the study of putative occupational determinants of disease. Occup Environ Med (2009) 0.89
Is objectively measured sitting time associated with low back pain? A cross-sectional investigation in the NOMAD study. PLoS One (2015) 0.89
Prevalence of Depression among Infertile Couples in Iran: A Meta-Analysis Study. Iran J Public Health (2013) 0.89
Earth Observation, Spatial Data Quality, and Neglected Tropical Diseases. PLoS Negl Trop Dis (2015) 0.88
Estimating population attributable fractions to quantify the health burden of obesity. Ann Epidemiol (2014) 0.88
The AQUA-FONTIS study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome. BMC Endocr Disord (2008) 0.88
Frequence, spectrum and prognostic impact of additional malignancies in patients with gastrointestinal stromal tumors. Neoplasia (2015) 0.88
Poor treatment outcomes among multidrug-resistant tuberculosis patients in Gomel Region, Republic of Belarus. Public Health Action (2014) 0.88
Understanding the motivations of health-care providers in performing female genital mutilation: an integrative review of the literature. Reprod Health (2017) 0.88
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med (1965) 40.52
The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med (2001) 37.70
Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA (1996) 36.04
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet (2006) 31.79
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet (2001) 31.74
Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA (2004) 23.87
No adjustments are needed for multiple comparisons. Epidemiology (1990) 23.80
Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ (2003) 18.72
Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet (2003) 18.24
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet (2002) 16.56
Bias in analytic research. J Chronic Dis (1979) 16.40
Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA (2003) 16.08
A comparison of observational studies and randomized, controlled trials. N Engl J Med (2000) 14.11
Use and misuse of population attributable fractions. Am J Public Health (1998) 12.96
Simulation study of confounder-selection strategies. Am J Epidemiol (1993) 12.76
Epidemiology faces its limits. Science (1995) 12.39
Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med (1998) 11.14
Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) (1983) 10.90
Estimates of global mortality attributable to smoking in 2000. Lancet (2003) 10.52
A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst (1951) 9.86
On the practice of dichotomization of quantitative variables. Psychol Methods (2002) 9.18
Sick individuals and sick populations. Int J Epidemiol (2001) 9.10
The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol (1999) 8.60
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med (2003) 8.58
Why review articles on the health effects of passive smoking reach different conclusions. JAMA (1998) 8.54
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med (2007) 8.46
More informative abstracts revisited. Ann Intern Med (1990) 8.26
Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med (2006) 8.25
Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA (2003) 8.21
Assessing the generalizability of prognostic information. Ann Intern Med (1999) 8.04
In defense of case reports and case series. Ann Intern Med (2001) 7.99
Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst (1994) 7.91
Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ (2003) 7.78
Full publication of results initially presented in abstracts. Cochrane Database Syst Rev (2007) 7.52
Bartenders' respiratory health after establishment of smoke-free bars and taverns. JAMA (1998) 7.14
Value of flow diagrams in reports of randomized controlled trials. JAMA (2001) 7.06
Risk factors for suicide in China: a national case-control psychological autopsy study. Lancet (2002) 7.00
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet (2002) 6.61
Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol (2005) 6.52
Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med (2007) 6.30
Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology (1997) 6.00
The "battering syndrome": prevalence and clinical characteristics of domestic violence in primary care internal medicine practices. Ann Intern Med (1995) 5.77
The effect of misclassification in the presence of covariates. Am J Epidemiol (1980) 5.66
Are health care professionals advising obese patients to lose weight? JAMA (1999) 5.63
The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics (1968) 5.54
Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law (1996) 5.49
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet (1994) 5.45
Limitations of the application of fourfold table analysis to hospital data. Biometrics (1946) 5.44
Quality of reporting of observational longitudinal research. Am J Epidemiol (2005) 5.25
Attributable risk percent in case-control studies. Br J Prev Soc Med (1971) 5.21
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2001) 5.18
Smoking and lung cancer: recent evidence and a discussion of some questions. J Natl Cancer Inst (1959) 4.88
REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer (2005) 4.85
Concepts of interaction. Am J Epidemiol (1980) 4.80
Quantification of the completeness of follow-up. Lancet (2002) 4.77
Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ (2004) 4.69
Effect of restrictions on smoking at home, at school, and in public places on teenage smoking: cross sectional study. BMJ (2000) 4.65
Habitual caffeine intake and the risk of hypertension in women. JAMA (2005) 4.46
Chronic stress at work and the metabolic syndrome: prospective study. BMJ (2006) 4.44
Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet (2006) 4.42
Sample size calculations in randomised trials: mandatory and mystical. Lancet (2005) 4.30
The rhetoric of research. BMJ (1995) 4.20
Randomization, statistics, and causal inference. Epidemiology (1990) 4.16
The case for structuring the discussion of scientific papers. BMJ (1999) 4.16
Review of survival analyses published in cancer journals. Br J Cancer (1995) 4.10
Assessing the quality of research. BMJ (2004) 3.90
Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med (1995) 3.88
Data, design, and background knowledge in etiologic inference. Epidemiology (2001) 3.82
Biased estimation of the odds ratio in case-control studies due to the use of ad hoc methods of correcting for missing values for confounding variables. Am J Epidemiol (1991) 3.72
Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J (2003) 3.55
Controlling for continuous confounders in epidemiologic research. Epidemiology (1997) 3.42
Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst (2005) 3.41
How independent are "independent" effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol (1991) 3.37
Semi-automated sensitivity analysis to assess systematic errors in observational data. Epidemiology (2003) 3.30
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Source of funding and outcome of clinical trials. J Gen Intern Med (1986) 3.21
Interpreting incomplete data in studies of diet and weight loss. N Engl J Med (2003) 3.14
Analysis of semi-parametric regression models with non-ignorable non-response. Stat Med (1997) 2.93
Factors relevant to the validity of experiments in social settings. Psychol Bull (1957) 2.91
Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. N Engl J Med (2000) 2.83
Role of mobile phones in motor vehicle crashes resulting in hospital attendance: a case-crossover study. BMJ (2005) 2.80
The British Regional Heart Study 1975-2004. Int J Epidemiol (2004) 2.72
Applications of multiple imputation in medical studies: from AIDS to NHANES. Stat Methods Med Res (1999) 2.71
Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. Epidemiology (1995) 2.71
Control of confounding in the assessment of medical technology. Int J Epidemiol (1980) 2.65
The importance of assessing the fit of logistic regression models: a case study. Am J Public Health (1991) 2.62
Quantifying and reporting uncertainty from systematic errors. Epidemiology (2003) 2.55
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med (2004) 2.39
Case-control studies: research in reverse. Lancet (2002) 2.38
A nested case-control study of residential and personal magnetic field measures and miscarriages. Epidemiology (2002) 2.37
Looking through a keyhole at the tobacco industry. The Brown and Williamson documents. JAMA (1995) 2.36
How to write an effective discussion. Respir Care (2004) 2.35
Dynamics of Helicobacter pylori infection in a US-Mexico cohort during the first two years of life. Int J Epidemiol (2005) 2.33
Most published research findings are false-but a little replication goes a long way. PLoS Med (2007) 2.26
Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol (1990) 2.26
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 34.99
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet (2006) 31.79
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA (2004) 23.87
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol (2009) 17.92
Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol (2010) 17.30
CONSORT statement: extension to cluster randomised trials. BMJ (2004) 16.50
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med (2010) 16.11
Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52
Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med (2010) 14.43
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol (2008) 14.36
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Neighborhood characteristics associated with the location of food stores and food service places. Am J Prev Med (2002) 13.39
Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One (2008) 13.32
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (2010) 12.98
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA (2006) 11.87
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80
Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS (2009) 11.62
Epidemiology and reporting characteristics of systematic reviews. PLoS Med (2007) 11.51
Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (2008) 11.08
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ (2004) 10.75
Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet (2004) 9.88
Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst (2005) 9.38
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med (2010) 9.30
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med (2007) 8.77
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet (2004) 8.77
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ (2008) 8.70
Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One (2009) 8.58
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet (2009) 8.54
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med (2007) 8.46
Developing core outcome sets for clinical trials: issues to consider. Trials (2012) 8.39
Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ (2009) 8.31
Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med (2006) 8.25
SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21
Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet (2005) 7.89
Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol (2009) 7.86
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis. N Engl J Med (2007) 7.86
Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 7.78
Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLoS One (2009) 7.60
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55
Consort 2010 statement: extension to cluster randomised trials. BMJ (2012) 7.47